Shaoping Ji

2.9k total citations
85 papers, 2.2k citations indexed

About

Shaoping Ji is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shaoping Ji has authored 85 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 18 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Shaoping Ji's work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and Sirtuins and Resveratrol in Medicine (8 papers). Shaoping Ji is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and Sirtuins and Resveratrol in Medicine (8 papers). Shaoping Ji collaborates with scholars based in China, Canada and United States. Shaoping Ji's co-authors include Wenqiang Wei, Adil J. Nazarali, Fengling Wang, Yang An, Kendra L. Furber, Xiangqian Guo, Libo Yao, Xin‐Ying Ji, Xinping Liu and Hua Han and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Shaoping Ji

84 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoping Ji China 22 1.6k 638 305 188 174 85 2.2k
Natalya D. Bodyak United States 25 1.9k 1.2× 428 0.7× 370 1.2× 219 1.2× 257 1.5× 47 3.1k
Li Cheng China 29 1.2k 0.8× 707 1.1× 171 0.6× 240 1.3× 197 1.1× 146 2.3k
Roman A. Eliseev United States 26 1.5k 1.0× 314 0.5× 157 0.5× 191 1.0× 217 1.2× 49 2.2k
Nicola Perrotti Italy 30 1.4k 0.9× 304 0.5× 133 0.4× 228 1.2× 113 0.6× 92 2.4k
Takeo Sakurai Japan 25 641 0.4× 328 0.5× 288 0.9× 369 2.0× 227 1.3× 112 1.9k
Chull Hong United States 31 2.9k 1.8× 843 1.3× 341 1.1× 245 1.3× 168 1.0× 57 4.3k
Bo Ding China 27 1.5k 1.0× 372 0.6× 154 0.5× 260 1.4× 108 0.6× 110 2.5k
Whaseon Lee‐Kwon United States 28 1.6k 1.0× 251 0.4× 135 0.4× 377 2.0× 195 1.1× 56 2.5k
Bianca C. Bernardo Australia 28 2.4k 1.5× 1.0k 1.6× 198 0.6× 155 0.8× 124 0.7× 50 4.1k
Jie Yin China 31 1.6k 1.0× 829 1.3× 146 0.5× 478 2.5× 105 0.6× 161 3.1k

Countries citing papers authored by Shaoping Ji

Since Specialization
Citations

This map shows the geographic impact of Shaoping Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoping Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoping Ji more than expected).

Fields of papers citing papers by Shaoping Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoping Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoping Ji. The network helps show where Shaoping Ji may publish in the future.

Co-authorship network of co-authors of Shaoping Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoping Ji. A scholar is included among the top collaborators of Shaoping Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoping Ji. Shaoping Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Xiaoli, et al.. (2024). The clinical potential of 1,5-anhydroglucitol as biomarker in diabetes mellitus. Frontiers in Endocrinology. 15. 1471577–1471577. 4 indexed citations
2.
Khan, Faiz Ali, Dalia Fouad, Farid S. Ataya, et al.. (2024). FXR1 associates with and degrades PDZK1IP1 and ATOH8 mRNAs and promotes esophageal cancer progression. Biology Direct. 19(1). 104–104. 10 indexed citations
3.
Hou, Xiaoli, et al.. (2024). Dysregulation of protein succinylation and disease development. Frontiers in Molecular Biosciences. 11. 1407505–1407505. 6 indexed citations
4.
Ye, Wenling, Yong‐Xing He, Haiyang Zhong, et al.. (2023). Identification of CBPA as a New Inhibitor of PD-1/PD-L1 Interaction. International Journal of Molecular Sciences. 24(4). 3971–3971. 10 indexed citations
5.
Sun, Leilei, Shaoping Ji, Xuan Xie, et al.. (2023). Deciphering the interaction between Twist1 and PPARγ during adipocyte differentiation. Cell Death and Disease. 14(11). 764–764. 7 indexed citations
6.
Chen, Jiahao, Xinyu Li, Jialin Wu, et al.. (2023). Deciphering the Prognostic and Therapeutic Significance of Cell Cycle Regulator CENPF: A Potential Biomarker of Prognosis and Immune Microenvironment for Patients with Liposarcoma. International Journal of Molecular Sciences. 24(8). 7010–7010. 5 indexed citations
7.
Yang, Yanjie, et al.. (2023). Proteomics and Metabolomics Analysis Reveals the Toxicity of ZnO Quantum Dots on Human SMMC-7721 Cells. International Journal of Nanomedicine. Volume 18. 277–291. 6 indexed citations
8.
Khan, Faiz Ali, Usman Ayub Awan, Dandan Wang, et al.. (2022). Pseudogenes and Liquid Phase Separation in Epigenetic Expression. Frontiers in Oncology. 12. 912282–912282. 5 indexed citations
9.
Ding, Yong, et al.. (2021). Sex differences in changes in BMI and blood pressure in Chinese school-aged children during the COVID-19 quarantine. International Journal of Obesity. 45(9). 2132–2136. 29 indexed citations
10.
Zhang, Huijuan, Wenjing Chang, Jing Zhou, et al.. (2020). Destrin Contributes to Lung Adenocarcinoma Progression by Activating Wnt/β-Catenin Signaling Pathway. Molecular Cancer Research. 18(12). 1789–1802. 29 indexed citations
11.
Sun, Kai, Xuan Wang, Na Fang, et al.. (2020). SIRT2 suppresses expression of inflammatory factors via Hsp90‐glucocorticoid receptor signalling. Journal of Cellular and Molecular Medicine. 24(13). 7439–7450. 18 indexed citations
12.
Wang, Qiang, Yang An, Fengling Wang, et al.. (2020). OSchol: an online consensus survival web server for cholangiocarcinoma prognosis analysis. HPB. 23(4). 545–550. 2 indexed citations
13.
Wei, Wenqiang, et al.. (2020). Characterization of lamin B receptor of Sf9 cells and its fate during Autographa californica nucleopolyhedrovirus infection. Cytotechnology. 72(2). 315–325. 1 indexed citations
14.
Wei, Wenqiang & Shaoping Ji. (2018). Cellular senescence: Molecular mechanisms and pathogenicity. Journal of Cellular Physiology. 233(12). 9121–9135. 151 indexed citations
15.
Wei, Wenqiang, Hongju Wang, & Shaoping Ji. (2017). Paradoxes of the EphB1 receptor in malignant brain tumors. Cancer Cell International. 17(1). 21–21. 17 indexed citations
16.
Furber, Kendra L., et al.. (2017). RNA-binding Protein Quaking Stabilizes Sirt2 mRNA during Oligodendroglial Differentiation. Journal of Biological Chemistry. 292(13). 5166–5182. 39 indexed citations
17.
Ji, Shaoping, J. Ronald Doucette, & Adil J. Nazarali. (2016). Protocols for Cloning, Expression, and Functional Analysis of Sirtuin2 (SIRT2). Methods in molecular biology. 1436. 189–199. 1 indexed citations
18.
Fang, Na, Yu-hua Kang, Jiang Wu, et al.. (2014). HOXA11 gene is hypermethylation and aberrant expression in gastric cancer. Cancer Cell International. 14(1). 79–79. 19 indexed citations
19.
Zhang, Jing, Jicun Wang, Lifeng Wang, et al.. (2005). High Expression of <i>bcl-x<sub>L</sub></i> in K562 Cells and Its Role in the Low Sensitivity of K562 to Realgar-Induced Apoptosis. Acta Haematologica. 113(4). 247–254. 4 indexed citations
20.
Wang, Jicun, Hou-shan Lü, Xinping Liu, et al.. (2002). Functional Analysis of Discoidin Domain Receptor 2 in Synovial Fibroblasts in Rheumatoid Arthritis. Journal of Autoimmunity. 19(3). 161–168. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalya D. Bodyak Breakdown of academic impact, for papers by Li Cheng Breakdown of academic impact, for papers by Roman A. Eliseev Breakdown of academic impact, for papers by Nicola Perrotti Breakdown of academic impact, for papers by Takeo Sakurai Breakdown of academic impact, for papers by Chull Hong Breakdown of academic impact, for papers by Bo Ding Breakdown of academic impact, for papers by Whaseon Lee‐Kwon Breakdown of academic impact, for papers by Bianca C. Bernardo Breakdown of academic impact, for papers by Jie Yin
Rankless by CCL
2026